Philadelphia Trust Company’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-163,650
Closed -$1.56M 214
2017
Q1
$1.56M Buy
163,650
+31,150
+24% +$263K 0.13% 105
2016
Q4
$1.17M Buy
132,500
+60,850
+85% +$547K 0.09% 115
2016
Q3
$615K Sell
71,650
-10,800
-13% -$85.5K 0.05% 136
2016
Q2
$658K Buy
+82,450
New +$642K 0.06% 132
2016
Q1
Sell
-25,000
Closed -$224K 192
2015
Q4
$224K Buy
+25,000
New +$217K 0.02% 173

Other funds holding MDXG

Philadelphia Trust Company's MDXG Position: Q2 2017 in Review

Philadelphia Trust Company sold out of MiMedx Group (MDXG) in Q2 2017, closing a stake of 163,650 shares — an estimated $1.56M sold.

Philadelphia Trust Company first reported a position in MDXG in Q4 2015 and held it in 5 quarters. The position peaked at $1.56M in Q1 2017. 209 funds tracked by Wall St. Rank hold MDXG as of Q2 2017.

  • Philadelphia Trust Company reported no remaining MiMedx Group position as of Q2 2017 after selling out during the quarter.
  • Philadelphia Trust Company sold 163,650 MiMedx Group shares in Q2 2017, an estimated $1.56M.
  • Philadelphia Trust Company first reported a position in MiMedx Group in Q4 2015 and held it in 5 quarters.
  • Philadelphia Trust Company's MiMedx Group position peaked at $1.56M in Q1 2017.
  • 209 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2017.

Based on Philadelphia Trust Company's 13F filing for Q2 2017, filed 14 Aug 2017.